Prevalence, Mutation Patterns, and Effects on Protease Inhibitor Susceptibility of the L76V Mutation in HIV-1 Protease -- Young et al. 54 (11): 4903 Data Supplement - Supplemental material -- Antimicrobial Agents and Chemotherapy

Prevalence, Mutation Patterns, and Effects on Protease Inhibitor Susceptibility of the L76V Mutation in HIV-1 Protease
Antimicrob. Agents Chemother. Young et al. 54: 4903

Supplemental material

Files in this Data Supplement:

Supplemental file 1 - Table S1, number and percent of samples with PI resistance-associated mutations in combination with L76V in various groups and in all L76V-containing or -lacking samples. Table S2, percent of samples with PI resistance-associated mutations in groups defined by lopinavir susceptibility and presence or absence of L76V. Table S3, PI susceptibility and mutation prevalence in groups defined by PI resistance-associated mutation patterns with or without L76V.
Zipped MS Excel file, 22K.